Journal
ACS CENTRAL SCIENCE
Volume 5, Issue 2, Pages 270-276Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acscentsci.8b00679
Keywords
-
Categories
Funding
- National Institutes of Health, National Institute for General Medical Sciences [GM-124480]
- Jacobs Institute for Molecular Engineering for Medicine at Caltech
- National Science Foundation Division of Molecular and Cellular Biosciences Grant [MCB-1513007]
- NIH [K99GM129419]
- Ramon Areces Foundation
- National Science Foundation [OCI-1053575]
Ask authors/readers for more resources
There are few biocatalytic transformations that produce fluorine-containing molecules prevalent in modern pharmaceuticals. To expand the scope of biocatalysis for organofluorine synthesis, we have developed an enzymatic platform for highly enantioselective carbene BH bond insertion to yield versatile alpha-trifluoromethylated (alpha-CF3) organoborons, an important class of organofluorine molecules that contain stereogenic centers bearing both CF3 and boron groups. In contrast to current carbene transferase enzymes that use a limited set of simple diazo compounds as carbene precursors, this system based on Rhodothermus marinus cytochrome c (Rma cyt c) can accept a broad range of trifluorodiazo alkanes and deliver versatile chiral alpha-CF3 organoborons with total turnovers up to 2870 and enantiomeric ratios up to 98.5:1.5. Computational modeling reveals that this broad diazo scope is enabled by an active-site environment that directs the alkyl substituent on the heme CF3-carbene intermediate toward the solvent-exposed face, thereby allowing the protein to accommodate diazo compounds with diverse structural features.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available